Jill Buck Alaunos Therapeutics, Inc. (TCRT) insider trading activity

TCRT Quotes by TradingView

Jill Buck is EVP, GM Gene Therapy of Alaunos Therapeutics, Inc.. Currently has a direct ownership of 231,016 shares of TCRT, which is worth approximately $480,513. The most recent transaction as insider was on Mar 04, 2021, when has been sold 31,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 231K
0% 3M change
0% 12M change
Total Value Held $480,513

Jill Buck Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 04 2021
BUY
Grant, award, or other acquisition
-
31,500 Added 12.0%
231,016 Common Stock
Jan 08 2021
SELL
Open market or private sale
$87,029 $3.12 p/Share
27,894 Reduced 12.27%
199,516 Common Stock
JB

Jill Buck

EVP, GM Gene Therapy
Boston, MA

Track Institutional and Insider Activities on TCRT

Follow Alaunos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRT shares.

Notify only if

Insider Trading

Get notified when an Alaunos Therapeutics, Inc. insider buys or sells TCRT shares.

Notify only if

News

Receive news related to Alaunos Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TCRT